InvestorsHub Logo
Followers 2
Posts 2022
Boards Moderated 0
Alias Born 05/11/2017

Re: James salmon post# 106707

Thursday, 01/21/2021 3:27:45 PM

Thursday, January 21, 2021 3:27:45 PM

Post# of 108192
No news? I'd guess this run could be attributed (at least, partially) to the failure of GSK/Merck Serono's bintrafusp alfa for NSCLC. They might be looking for a potential candidate to replace that failed drug. HOT could be that candidate.

https://endpts.com/glaxosmithklines-4b-bispecific-cancer-drug-alliance-with-merck-kgaa-rattled-by-a-trial-flop-for-nsclc/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News